RecallDepth
Class II Terminated

Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
November 1, 2020
Posted
November 25, 2020
Recall Number
D-0077-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
99 bottles (9990 Extended Release Tablets)
Firm Location
Anaheim, CA, United States

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Distribution

Distributed to two physician's offices located in FL.

Lot / Code Info

E0620F, Exp.12/31/2021; G2020M Exp., 04/30/2022

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls